Clinical Trials · NCT01288326
Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 254
- Start date
- Feb 2011
- Locations
- 1 site, Belgium
- Primary endpoint
- Percentage of participants with a decrease in HbA1c (glycosylated haemoglobin A1c) of at least 1%